Skip to content
AnalystLens

James Hardie Industries 8-K Report (Mar 24, 2025)

Filing Date
Filed March 24, 2025
Period End
March 24, 2025
Securities
JHXJHIUF
In the record · 2016–202610-K1210-Q18-K401

JHX filed 12 annual reports (10-K), 1 quarterly reports (10-Q) and 401 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 6-K filed March 24, 2025. Cited figures are marked; the original filing is the authoritative source.

James Hardie Industries plc (JHX) has entered into a definitive Agreement and Plan of Merger, dated March 23, 2025, under which it will acquire The AZEK Company Inc. (NYSE: AZEK) through a combination of cash and James Hardie shares, with a total transaction value of $8.75 billiona, including AZEK's net debt of approximately $386 million as of December 31, 2024.

AZEK shareholders will receive $26.45b in cash and 1.0340 ordinary shares of James Hardie for each AZEK share, a total per-share value of $56.88 based on the March 21, 2025 closing price of AU$46.80 per CDI. Upon completion, James Hardie and AZEK shareholders are expected to own approximately 74% and 26%, respectively, of the combined company, and James Hardie shares will be listed on the NYSE in addition to its ASX CDI listing. Management expects the transaction to be accretive to James Hardie's cash earnings per share in the first full fiscal year after closing, and to add at least $350 million of annual adjusted EBITDA from synergies when fully realized, consisting of at least $125 million of cost synergies and $500 million of commercial synergies.

On a combined basis for the 12 months ended December 31, 2024, the companies would have generated $5.9 billionc in net sales and more than $1.8 billion in adjusted EBITDA, including run-rate synergies. Pro forma leverage at close is expected to be approximately 2.8x net debt to LTM adjusted EBITDA, with a target below 2.0x by the end of the second full fiscal year after closing, and James Hardie plans up to $500 million of share repurchases in the 12 months after closing. The cash portion will be funded through debt financing backed by a fully committed bridge facility led by Bank of America and Jefferies LLC.

The transaction is expected to close in the second half of calendar year 2025, subject to AZEK shareholder approval, regulatory approvals and customary closing conditions. A James Hardie shareholder vote is not required.

Key Highlights

  1. Transaction value of $8.75 billion, including AZEK net debt of approximately $386 million as of December 31, 2024.
  2. Consideration per AZEK share: $26.45 in cash plus 1.0340 James Hardie ordinary shares, a total value of $56.88 based on the AU$46.80 CDI price on March 21, 2025.
  3. The per-share value represents a 26% premium to AZEK's 30-trading-day VWAP and a 21% premium to its 60-trading-day VWAP prior to March 21, 2025.
  4. Pro forma ownership of approximately 74% for James Hardie shareholders and 26% for AZEK shareholders.
  5. Expected at least $350 million of additional annual adjusted EBITDA from synergies, including at least $125 million of cost synergies and $500 million of commercial synergies.
  6. Pro forma leverage of approximately 2.8x net debt to LTM adjusted EBITDA at close, targeted below 2.0x within the second full fiscal year after closing; up to $500 million of share repurchases planned in the 12 months after closing.
  7. Expected close in the second half of calendar 2025, subject to AZEK shareholder approval, regulatory approvals and customary conditions.

Frequently Asked Questions

  1. What will AZEK shareholders receive?

    Each share of AZEK common stock will be exchanged for $26.45 in cash and 1.0340 ordinary shares of James Hardie, which the filing values at $56.88 per AZEK share based on the March 21, 2025 closing CDI price of AU$46.80.

  2. How will the transaction be financed?

    James Hardie intends to fund the cash portion through debt financing and has secured a fully committed bridge financing facility led by Bank of America and Jefferies LLC. The filing states that the transaction is not subject to a James Hardie shareholder vote.

  3. What synergies does management expect?

    Management expects at least $125 million of cost synergies and $500 million of commercial synergies, together delivering at least $350 million of additional annual adjusted EBITDA, with full run-rate cost synergies realized in year three and commercial synergies in year five after closing.

  4. What are the key conditions and timing for closing?

    The transaction is expected to close in the second half of calendar year 2025 and is subject to AZEK shareholder approval, regulatory approvals and other customary closing conditions. The merger agreement was unanimously approved by both companies' boards.

  5. How will the transaction affect James Hardie's leverage and capital returns?

    Pro forma leverage at close is expected to be approximately 2.8x net debt to LTM adjusted EBITDA, with a target below 2.0x by the end of the second full fiscal year after closing, inclusive of share repurchases. James Hardie plans to execute up to $500 million of share repurchases in the 12 months after closing.